Danielle Brill

Mar 18, 2026

Danielle Brill rated CLYM as Buy on Mar 18, 2026, setting a price target of 17. Shares have remained stable near 7.12, leaving the 17 target still in play.

Mar 18, 2026

MAZE received a Buy rating from Danielle Brill on Mar 18, 2026, aiming for 68. Price action was muted, as shares hovered around 50.39 despite the bullish outlook.

Mar 09, 2026

On Mar 09, 2026, Danielle Brill published a Buy outlook on DNTH, with a target of 110. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 78.9.

Feb 27, 2026

Danielle Brill on Feb 27, 2026 assigned IRON a Buy rating, with a price target of 114. The call has struggled to gain traction, with shares losing 9.97%.

Feb 25, 2026

On Feb 25, 2026, Danielle Brill reaffirmed BBIO with a Buy rating, targeting 95. The recommendation was supported by strong follow-through as the stock rose from 70.94 to 70.94.

Feb 17, 2026

NBIX was rated Buy by Danielle Brill on Feb 17, 2026, with a price objective of 169. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Jan 29, 2026

On Jan 29, 2026, Danielle Brill initiated coverage on CNTA with a Buy rating and target of 38. The stock’s climb of 16.31% since the call highlights the foresight in the rating.

Jan 08, 2026

Danielle Brill issued a Buy recommendation for ALNY on Jan 08, 2026, price target set at 535. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jan 08, 2026

On Jan 08, 2026, TECX was evaluated by Danielle Brill, who gave a Buy rating and target of 64. This case illustrates how a timely bullish rating can translate into tangible gains of 46.69%.

Jan 08, 2026

On Jan 08, 2026, HRMY was given a Buy rating by Danielle Brill, with a target price of 48. Despite the Buy call, shares fell from 28.37 to 28.37, challenging the optimistic stance.

Dec 16, 2025

PVLA received a Buy rating from Danielle Brill on Dec 16, 2025, aiming for 190. Momentum has favored the Buy call, with shares climbing from 120.8 to 120.8, rewarding those who trusted the recommendation.

Oct 14, 2025

On Oct 14, 2025, Danielle Brill published a Buy outlook on UPB, with a target of 47. Market action contradicted the Buy thesis, as shares slipped to 9.71.

Jul 21, 2025

On Jul 21, 2025, Danielle Brill reaffirmed JCAP with a Buy rating, targeting 24. The recommendation was supported by strong follow-through as the stock rose from 20.27 to 20.27.

Dec 10, 2024

QURE was rated Strong Buy by Danielle Brill on Dec 10, 2024, with a price objective of 52. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Oct 10, 2024

Danielle Brill rated AGIO as Outperform on Oct 10, 2024, setting a price target of 51. The stock has underperformed, dropping 30.87% despite the bullish target of 51.

Oct 10, 2024

On Oct 10, 2024, XENE was given a Outperform rating by Danielle Brill, with a target price of 50. The stock rallied 36.60% after the rating, narrowing the gap to the target of 50 and validating the bullish stance.

Oct 10, 2024

ARGX received a Strong Buy rating from Danielle Brill on Oct 10, 2024, aiming for 605. Momentum has favored the Buy call, with shares climbing from 706.03 to 706.03, rewarding those who trusted the recommendation.

Oct 10, 2024

On Oct 10, 2024, Danielle Brill published a Outperform outlook on RGNX, with a target of 18. Market action contradicted the Buy thesis, as shares slipped to 8.64.

Oct 10, 2024

Danielle Brill on Oct 10, 2024 assigned BMRN a Outperform rating, with a price target of 79. The call has struggled to gain traction, with shares losing 19.76%.

Oct 10, 2024

On Oct 10, 2024, Danielle Brill reaffirmed SRPT with a Outperform rating, targeting 150. Shares slid 86.24% despite the recommendation, highlighting downside risks.